Intermediate for Apixaban. Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.


Product Name:                  5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone

Synonyms:                         N/A

CAS Number:                     503615-03-0

Molecular Weight:            303.317

Molecular Formula:          C15H17N3O4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C1C(=CCCN1c1ccc(cc1)[N+](=O)[O-])N1CCOCC1


  • $207.00
  • Ex Tax: $207.00

Available Options